News-Medical.Net on MSN
Combination therapy may boost survival for people with aggressive lymphoma
A new clinical trial suggests that pairing bispecific antibodies and antibody-drug conjugates with CAR T-cell therapy may ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback